Leo Cancer Care aspires to challenge the norms in Radiation Therapy to deliver an improved patient experience and care. Our innovative products are based on data and studies that indicate the evergrowing benefits of upright patient positioning. We believe shifting from machine rotation to patient rotation in the upright position will change the face of radiation therapy for good.
KEY INDICATIONS UPRIGHT
Learn more about the potential clinical benefits of upright patient positioning, each referencing existing research and whitepapers.
MOTION AND SETUP REPRODUCIBILITY UPRIGHT
Reference: S. Boisbouvier, A. Boucaud, R. Tanguy, V. Grégoire (2022) Upright patient positioning for pelvic radiotherapy treatments https://doi.org/10.1016/j.tipsro.2022.11.003
ECONOMIC BENEFITS
The clinical community is searching for solutions that will fit rapidly changing financial realities. Our family of products are designed for the economics of the future.
IMPROVED PATIENT EXPERIENCE
We hear from patients that the treatment journey is an extremely vulnerable time. Even the smallest moments of feeling in control can be empowering. Our aim has always and will always be to be the more human way to treat cancer, beginning with how you feel during your treatment.
PATIENTS INDICATE UPRIGHT WILL BE MORE COMFORTABLE
Reference: S. Boisbouvier, A. Boucaud, R. Tanguy, V. Grégoire (2022) Upright patient positioning for pelvic radiotherapy treatments https://doi.org/10.1016/j.tipsro.2022.11.003
MEET OUR SCIENTIFIC ADVISORY BOARD
Influential clinicians helping us to find a better way.
It is very important to align with thought leaders in the industry when developing new technologies. At Leo Cancer Care we want to ensure that our solutions address the needs of patients, clinicians and industry by actively engaging with experts in the field, that is why we created our own Scientific Advisory Board.
Members include; Jay Flanz, Laurence Court, Mark Pankuch, James Welsh, Tony Lomax, Vincent Gregoire & Aswin Hoffmann.
Continue learning more about upright radiotherapy with previous presentations and whitepapers in our resource centre:
*The Leo Cancer Care technology is not commercially available and will not treat patients until the required regulatory approval has been achieved